Cargando…

HNC0014, a Multi-Targeted Small-Molecule, Inhibits Head and Neck Squamous Cell Carcinoma by Suppressing c-Met/STAT3/CD44/PD-L1 Oncoimmune Signature and Eliciting Antitumor Immune Responses

SIMPLE SUMMARY: Cancer stem cells (CSCs) in head and neck squamous cell carcinoma (HNSCC) possess unlimited self-renewal capacity, resist treatments and induce tumor repopulation after interventions. Here, we observed HNSCC CSCs secreted exosomes containing c-Met, STAT3 (also the phosphorylated form...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Jih-Chin, Wu, Alexander T.H., Chen, Jia-Hong, Huang, Wen-Yen, Lawal, Bashir, Mokgautsi, Ntlotlang, Huang, Hsu-Shan, Ho, Ching-Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764918/ https://www.ncbi.nlm.nih.gov/pubmed/33327484 http://dx.doi.org/10.3390/cancers12123759

Ejemplares similares

An Integrated Bioinformatics Study of a Novel Niclosamide Derivative, NSC765689, a Potential GSK3β/β-Catenin/STAT3/CD44 Suppressor with Anti-Glioblastoma Properties
por: Mokgautsi, Ntlotlang, et al.
Publicado: (2021)

Pharmacoinformatics and Preclinical Studies of NSC765690 and NSC765599, Potential STAT3/CDK2/4/6 Inhibitors with Antitumor Activities against NCI60 Human Tumor Cell Lines
por: Lawal, Bashir, et al.
Publicado: (2021)

Network Pharmacological Analysis through a Bioinformatics Approach of Novel NSC765600 and NSC765691 Compounds as Potential Inhibitors of CCND1/CDK4/PLK1/CD44 in Cancer Types
por: Mokgautsi, Ntlotlang, et al.
Publicado: (2021)

Targeting Oncoimmune Drivers of Cancer Metastasis
por: Kudo-Saito, Chie, et al.
Publicado: (2021)

A Preclinical Investigation of GBM-N019 as a Potential Inhibitor of Glioblastoma via Exosomal mTOR/CDK6/STAT3 Signaling
por: Wu, Alexander T. H., et al.
Publicado: (2021)

mTOR/EGFR/iNOS/MAP2K1/FGFR/TGFB1 Are Druggable Candidates for N-(2,4-Difluorophenyl)-2′,4′-Difluoro-4-Hydroxybiphenyl-3-Carboxamide (NSC765598), With Consequent Anticancer Implications
por: Lawal, Bashir, et al.
Publicado: (2021)

Identification of CDK1, PBK, and CHEK1 as an Oncogenic Signature in Glioblastoma: A Bioinformatics Approach to Repurpose Dapagliflozin as a Therapeutic Agent
por: Chinyama, Harold A., et al.
Publicado: (2023)

Comprehensive Omics Analysis of a Novel Small-Molecule Inhibitor of Chemoresistant Oncogenic Signatures in Colorectal Cancer Cell with Antitumor Effects
por: Huang, Tse-Hung, et al.
Publicado: (2021)

DVS for release 0.0.14: Workshop
por: Kazarov, A
Publicado: (2001)

EHMTI-0014. A case of ice-pick headache
por: Tertan, D, et al.
Publicado: (2014)

The Role of Proprotein Convertases in the Regulation of the Function of Immune Cells in the Oncoimmune Response
por: Rose, Mélanie, et al.
Publicado: (2021)

Preclinical Identification of Sulfasalazine’s Therapeutic Potential for Suppressing Colorectal Cancer Stemness and Metastasis through Targeting KRAS/MMP7/CD44 Signaling
por: Leung, Wai-Hung, et al.
Publicado: (2022)

In Vitro and In Silico Biological Studies of 4-Phenyl-2-quinolone (4-PQ) Derivatives as Anticancer Agents
por: Chen, Yi-Fong, et al.
Publicado: (2023)

The ICOSL Expression Predicts Better Prognosis for Nasopharyngeal Carcinoma via Enhancing Oncoimmunity
por: Zhang, Geng, et al.
Publicado: (2020)

Oncolytic viruses are a recent breakthrough in oncoimmune treatment: recent insights – correspondence
por: Amin, Ruhul, et al.
Publicado: (2023)

In-Silico Evaluation of Genetic Alterations in Ovarian Carcinoma and Therapeutic Efficacy of NSC777201, as a Novel Multi-Target Agent for TTK, NEK2, and CDK1
por: Khedkar, Harshita Nivrutti, et al.
Publicado: (2021)

Multi-Omics Identification of Genetic Alterations in Head and Neck Squamous Cell Carcinoma and Therapeutic Efficacy of HNC018 as a Novel Multi-Target Agent for c-MET/STAT3/AKT Signaling Axis
por: Khedkar, Harshita Nivrutti, et al.
Publicado: (2023)

Ras and Wnt Interaction Contribute in Prostate Cancer Bone Metastasis
por: Lin, Shian-Ren, et al.
Publicado: (2020)

Minimally invasive detection of cancer using metabolic changes in tumor-associated natural killer cells with Oncoimmune probes
por: Ishwar, Deeptha, et al.
Publicado: (2022)

Paucity of HPV-Related Head and Neck Cancers (HNC) in Nigeria
por: Oga, Emmanuel A., et al.
Publicado: (2016)

Hydrogen bonding capabilities of group 14 homologues of HCN and HNC
por: Bautista-Renedo, Joanatan M., et al.
Publicado: (2019)

In Silico Evaluation of HN-N07 Small Molecule as an Inhibitor of Angiogenesis and Lymphangiogenesis Oncogenic Signatures in Non-Small Cell Lung Cancer
por: Chen, Lung-Ching, et al.
Publicado: (2023)

Salivary Cytokines in patients with Head and Neck Cancer (HNC) treated with Radiotherapy
por: Principe, Sara, et al.
Publicado: (2019)

Multiomics Study of a Novel Naturally Derived Small Molecule, NSC772864, as a Potential Inhibitor of Proto-Oncogenes Regulating Cell Cycle Progression in Colorectal Cancer
por: Mokgautsi, Ntlotlang, et al.
Publicado: (2023)

P.0014 Alcohol use, anger, aggression, resilience, and family support during the Covid-19 lockdown in Greece
por: Pachi, A., et al.
Publicado: (2021)

Development and validation of the HNC-LL score for predicting the severity of coronavirus disease 2019
por: Xiao, Lu-shan, et al.
Publicado: (2020)

Flubendazole Elicits Antitumor Effects by Inhibiting STAT3 and Activating Autophagy in Non-small Cell Lung Cancer
por: Xie, Xiaona, et al.
Publicado: (2021)

Preclinical Evaluation of a Novel Small Molecule LCC-21 to Suppress Colorectal Cancer Malignancy by Inhibiting Angiogenic and Metastatic Signatures
por: Mokgautsi, Ntlotlang, et al.
Publicado: (2023)

Loss of exosomal miR-3188 in cancer-associated fibroblasts contributes to HNC progression
por: Wang, Xiaoning, et al.
Publicado: (2019)

Patterns of Immune Infiltration in HNC and Their Clinical Implications: A Gene Expression-Based Study
por: Song, Jukun, et al.
Publicado: (2019)

BMSC–HNC Interaction: Exploring Effects on Bone Integrity and Head and Neck Cancer Progression
por: Eichberger, Jonas, et al.
Publicado: (2023)

Colocalized targeting of TGF-β and PD-L1 by bintrafusp alfa elicits distinct antitumor responses
por: Lan, Yan, et al.
Publicado: (2022)

Responses to the Tepotinib in Gastric Cancers with MET Amplification or MET Exon 14 Skipping Mutations and High Expression of Both PD-L1 and CD44
por: Sohn, Sung-Hwa, et al.
Publicado: (2022)

Psychosocial Distress of Head Neck Cancer (HNC) Patients Receiving Radiotherapy: A Systematic Review
por: Nayak, Shalini G, et al.
Publicado: (2022)

Anticancer Activities of 9-chloro-6-(piperazin-1-yl)-11H-indeno[1,2-c] quinolin-11-one (SJ10) in Glioblastoma Multiforme (GBM) Chemoradioresistant Cell Cycle-Related Oncogenic Signatures
por: Mokgautsi, Ntlotlang, et al.
Publicado: (2022)

Use of 0.014-in. pushable bare platinum coils in super-selective embolization through the 1.6-Fr. microcatheter of the triaxial system
por: Tsukahara, Satoshi, et al.
Publicado: (2020)

Celastrol elicits antitumor effects by inhibiting the STAT3 pathway through ROS accumulation in non-small cell lung cancer
por: Zhao, Zhucheng, et al.
Publicado: (2022)

Intratumoral delivery of a novel oncolytic adenovirus encoding human antibody against PD-1 elicits enhanced antitumor efficacy
por: Zhou, Ping, et al.
Publicado: (2022)

Extranodal presentation in limited-stage diffuse large B-cell lymphoma as a prognostic marker in three SWOG trials S0014, S0313 and S1001
por: Stephens, Deborah M., et al.
Publicado: (2022)

Development of Prediction Model for Mean Parotid Dose of HNC Undergoing Radiotherapy - A Single Institutional Study
por: Bera, Soumen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_31vug3suc5v8b0qugl64og8u6k